Clinical Trials
3 trialsNCT02343549 2022-11-03
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT00365222 2009-01-22
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated